Barrington Research today reiterated a Buy rating on IMAX Corporation (NYSE: IMAX) and trimmed its price target to $36 from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE